Elevated Plasma Levels of Soluble Receptors of TNF-  and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes

2001 ◽  
Vol 86 (8) ◽  
pp. 3805-3808 ◽  
Author(s):  
G. Zoppini
2017 ◽  
Author(s):  
Yuliya Dydyshka ◽  
Alla Shepelkevich ◽  
Vladislav Yurkovets ◽  
Elena Brutskaya-Stempkovskaya ◽  
Marina Mantachik

2009 ◽  
Vol 16 (02) ◽  
pp. 178-186
Author(s):  
MUHAMMAD USMAN KHURSHID ◽  
MANSOOR-UL-HASSAN ALV I

A i m s & O b j e c t i v e s : To test the hypothesis that an increased plasma concentration of sialic acid, a marker of the acutephaseresponse, is related to the presence of diabetic retinopathy in type 1 diabetes mellitus or Insulin Dependant Diabetes Mellitus (IDDM).R e s e a r c h D e s i g n a n d M e t h o d s : We investigated the relationship between plasma sialic acid concentration and diabetic retinopathy in across-sectional survey of 1,369 people with type 1 diabetes. Subjects were participants in the IDDM Complications Study, which involveddiabetic centers of four different hospitals in Lahore. Results: There was a significantly increasing trend of plasma sialic acid with severityof retinopathy (P < 0.001 in men) and with degree of urinary albumin excretion (P < 0.001 men, P < 0.01 women). Elevated plasma sialicacid concentrations were also associated with several risk factors for diabetic vascular disease: diabetes duration, HbAlc, plasma triglycerideand cholesterol concentrations, waist-to-hip ratio, hypertension and smoking (in men), and low physical exercise (in women). In multiplelogistic regression analysis, plasma sialic acid was independently related to proliferative retinopathy and urinary albumin excretion rate inmen. Conclusions: We concluded that an elevated plasma sialic concentration is strongly related to the presence of microvascularcomplications in type 1 diabetes with retinopathy and nephropathy. Further study of acute-phase response markers and mediators asindicators or predictors of diabetic microvascular complications is therefore justified.


2015 ◽  
Vol 29 (8) ◽  
pp. 1105-1111 ◽  
Author(s):  
Pawel Niedzwiecki ◽  
Stanislaw Pilacinski ◽  
Aleksandra Uruska ◽  
Anna Adamska ◽  
Dariusz Naskret ◽  
...  

Author(s):  
Isabel Inácio ◽  
Sara Ferrreira ◽  
Patrícia Rosinha ◽  
Teresa Azevedo ◽  
Márcia Alves ◽  
...  

1997 ◽  
Vol 73 (859) ◽  
pp. 293-294 ◽  
Author(s):  
R. N. Sinha ◽  
A. W. Patrick ◽  
L. Richardson ◽  
M. Wallymahmed ◽  
I. A. MacFarlane

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Kailash Singh ◽  
Stellan Sandler ◽  
Daniel Espes

Aim.To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications.Methods.Plasma levels of VEGF and routine clinical parameters were analyzed in 115 patients with long-standing T1D and 45 healthy controls (HC). All patients were under clinical routine diabetes treatment at Uppsala University Hospital.Results.The plasma levels of VEGF were increased by 37% in patients with T1D when compared to HC (18.2±0.8versus13.2±1.0 pg/ml,p<0.001). The levels of VEGF correlated to insulin needs and BMI but not to present or historical metabolic control. The levels of VEGF were similar in patients with T1D and microvascular complications (microalbuminuria and retinopathy) when compared with patients without microvascular complications. Historical HbA1c levels were found to be the best predictor for present metabolic control.Conclusion.Circulating plasma levels of VEGF do not correlate to present or historical metabolic control in long-standing T1D and the levels are not affected by the presence of microvascular complications.


Sign in / Sign up

Export Citation Format

Share Document